ATE110568T1 - Pharmazeutisches präparat zur behandlung des katarakts. - Google Patents

Pharmazeutisches präparat zur behandlung des katarakts.

Info

Publication number
ATE110568T1
ATE110568T1 AT87117637T AT87117637T ATE110568T1 AT E110568 T1 ATE110568 T1 AT E110568T1 AT 87117637 T AT87117637 T AT 87117637T AT 87117637 T AT87117637 T AT 87117637T AT E110568 T1 ATE110568 T1 AT E110568T1
Authority
AT
Austria
Prior art keywords
cataract
treatment
pharmaceutical preparation
compound
remedies
Prior art date
Application number
AT87117637T
Other languages
English (en)
Inventor
Shinji Terao
Mitsuyoshi Azuma
Noriko Watanabe
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE110568T1 publication Critical patent/ATE110568T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT87117637T 1986-12-03 1987-11-28 Pharmazeutisches präparat zur behandlung des katarakts. ATE110568T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28807686 1986-12-03

Publications (1)

Publication Number Publication Date
ATE110568T1 true ATE110568T1 (de) 1994-09-15

Family

ID=17725491

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87117637T ATE110568T1 (de) 1986-12-03 1987-11-28 Pharmazeutisches präparat zur behandlung des katarakts.

Country Status (8)

Country Link
US (1) US4826872A (de)
EP (1) EP0270046B1 (de)
KR (1) KR950007099B1 (de)
CN (1) CN1016313B (de)
AT (1) ATE110568T1 (de)
CA (1) CA1300504C (de)
DE (1) DE3750464T2 (de)
ES (1) ES2059348T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871350A (en) * 1986-11-04 1989-10-03 Baylor College Of Medicine Methods and compositions for preventing secondary cataracts
US4966577A (en) * 1988-03-16 1990-10-30 Allergan, Inc. Prevention of lens-related tissue growth in the eye
US5627162A (en) * 1990-01-11 1997-05-06 Gwon; Arlene E. Methods and means for control of proliferation of remnant cells following surgery
US6046019A (en) * 1991-07-09 2000-04-04 Goumeniouk; Alexander P. Diagnostic kits and methods for making granulocyte cell counts
TW325997B (en) * 1993-02-02 1998-02-01 Senju Pharma Co Pharmaceutical composition for preventing and treating retinal diseases
CA2334312A1 (en) 1998-06-26 2000-01-06 Takara Shuzo Co., Ltd. Therapeutic agents
ATE528009T1 (de) * 2002-04-30 2011-10-15 Sifi Spa Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten
US20040229814A1 (en) * 2002-08-28 2004-11-18 James Dillon Methods and compositions for protecting against cataract development associated with vitrectomies
US20070166402A1 (en) * 2005-12-12 2007-07-19 Friedlaender Mitchell H Compositions, methods and kits for removing debris from an ocular area

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60130582A (ja) * 1983-12-19 1985-07-12 Takeda Chem Ind Ltd 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法
EP0189272A3 (de) * 1985-01-17 1987-08-19 Fujisawa Pharmaceutical Co., Ltd. Furanonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production

Also Published As

Publication number Publication date
EP0270046A2 (de) 1988-06-08
ES2059348T3 (es) 1994-11-16
KR880007070A (ko) 1988-08-26
EP0270046A3 (en) 1990-06-13
EP0270046B1 (de) 1994-08-31
CA1300504C (en) 1992-05-12
DE3750464D1 (de) 1994-10-06
KR950007099B1 (ko) 1995-06-30
US4826872A (en) 1989-05-02
DE3750464T2 (de) 1995-02-09
CN1016313B (zh) 1992-04-22
CN87107231A (zh) 1988-07-06

Similar Documents

Publication Publication Date Title
ES2053587T3 (es) Nuevos derivados de bencimidazoles activos como agentes anti-ulcera.
SG15593G (en) Phenoxyacetic acid compounds,their preparation,pharmaceutical composition and use
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
SE8600658D0 (sv) Novel composition of matter
ES2028838T3 (es) Procedimiento para la obtencion de nuevos derivados de 4,5-hidro-oxazoles.
DE3786865T2 (de) Aminosäurederivate enthaltende antikonvulsive Zusammensetzungen und Verwendung dieser Aminosäurederivate.
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE3884878D1 (de) Uricosuretische Zusammensetzung.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3784883D1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.
PH22441A (en) Quinate salts of the antimaterial compound mefloquine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee